Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,359,110
-$4,313,249 QoQ
Shares Held
606,523
-38.8% QoQ
Ownership
0.786%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#30
of 422 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026First Pacific Advisors, LP holds $437,970,431 across 4 Diagnostics & Research names. ICLR ranks #3 (24.1% of the industry book) .
All Filings in ICLR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,359,110 | 606,523 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $109,672,359 | 991,075 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $178,722,104 | 980,804 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $170,506,875 | 974,325 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $140,231,254 | 964,120 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $95,710,255 | 546,947 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $94,737,960 | 451,757 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $101,608,905 | 353,656 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $111,805,344 | 356,670 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $117,790,453 | 350,619 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $99,305,485 | 350,816 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $85,223,677 | 346,086 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $87,820,200 | 351,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $76,444,715 | 357,904 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $69,781,593 | 359,236 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $31,835,841 | 173,228 | Shares | Sole | 2022-11-04 | |
| No filing history on record for this holder in this stock. | ||||||